Literature DB >> 11155440

Regulation of Th1 and Th2 immune responses by chemokines.

H Yoneyama1, S Kawasaki, K Matsushima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11155440     DOI： 10.1007/s002810000050

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  72 in total

Review 1.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

Authors:  P Kaliński; C M Hilkens; E A Wierenga; M L Kapsenberg
Journal:  Immunol Today       Date:  1999-12

2.  Interaction within clusters of dendritic cells and helper T cells during initial Th1/Th2 commitment.

Authors:  D M Schuhbauer; N A Mitchison; B Mueller
Journal:  Eur J Immunol       Date:  2000-05       Impact factor: 5.532

Review 3.  Is BALT a major component of the human lung immune system?

Authors:  R Pabst
Journal:  Immunol Today       Date:  1992-04

4.  Visualization of specific B and T lymphocyte interactions in the lymph node.

Authors:  P Garside; E Ingulli; R R Merica; J G Johnson; R J Noelle; M K Jenkins
Journal:  Science       Date:  1998-07-03       Impact factor: 47.728

5.  Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.

Authors:  D D'Ambrosio; A Iellem; R Bonecchi; D Mazzeo; S Sozzani; A Mantovani; F Sinigaglia
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

6.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells.

Authors:  F Sallusto; E Kremmer; B Palermo; A Hoy; P Ponath; S Qin; R Förster; M Lipp; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

Review 7.  Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines.

Authors:  M C Dieu-Nosjean; A Vicari; S Lebecque; C Caux
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

8.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

9.  Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells.

Authors:  V N Ngo; H L Tang; J G Cyster
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

10.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.

Authors:  J Estaquier; T Idziorek; W Zou; D Emilie; C M Farber; J M Bourez; J C Ameisen
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307
View more
  4 in total

1.  Neutralization of CXCL10 accelerates liver regeneration in carbon tetrachloride-induced acute liver injury.

Authors:  Hiroyuki Yoneyama; Yoshiro Kai; Jun Koyama; Kenji Suzuki; Hiroshi Kawachi; Shosaku Narumi; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

Review 2.  Drugs for paediatric hyperinflammatory syndromes.

Authors:  Kam Lun Hon; Alexander Kc Leung; Wing Hang Leung; Karen Ka Yan Leung; Kai Ning Cheong; Pamela Pw Lee
Journal:  Drugs Context       Date:  2022-05-27

3.  Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis.

Authors:  Thomas Klein; Masato Fujii; Jan Sandel; Yuichiro Shibazaki; Kyoko Wakamatsu; Michael Mark; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-09-19       Impact factor: 2.309

4.  Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes.

Authors:  Hiroyuki Yoneyama; Shosaku Narumi; Yanyun Zhang; Masako Murai; Marco Baggiolini; Antonio Lanzavecchia; Takafumi Ichida; Hitoshi Asakura; Kouji Matsushima
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.